aibioSNYRQ Synergy CHC Corp.
Synergy CHC (SNYRQ) news
Synergy CHC Corp. is a public biotech or pharmaceutical company listed on OTC under the ticker SNYRQ, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Latest Synergy CHC news
We have not published a story on Synergy CHC yet. When there is news, it will appear here.
Synergy CHC annual financials
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $30.4 million | $34.8 million |
| Net income (loss) | -$12.3 million | $2.1 million |
| Cash from operations | -$2.6 million | -$4.8 million |
| Cash and equivalents | $2.6 million | $687,920 |
Questions about Synergy CHC
What is the ticker symbol of Synergy CHC?
Synergy CHC Corp. trades under the ticker SNYRQ on OTC.
Where is Synergy CHC listed?
Synergy CHC Corp. is listed on OTC.
Which country or territory is Synergy CHC listed under?
Our directory records Synergy CHC Corp. under United States.
Does aibio.space cover Synergy CHC?
aibio.space lists Synergy CHC Corp. among 2,820 public biotech companies and publishes its news here as stories appear.
What was Synergy CHC's revenue last year?
$30.4 million for the fiscal year ended Dec 31, 2025, as reported to the SEC.
Is Synergy CHC profitable?
Synergy CHC Corp. reported a net loss of $12.3 million for the fiscal year ended Dec 31, 2025, and used $2.6 million of cash in operations, per its annual report to the SEC.
How much cash does Synergy CHC have?
$292,115 in cash at Mar 31, 2026, per its 10-Q.
Investor discussion: Synergy CHC
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Capital-markets timeline
- Listings
Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01). Source
- Distress
Reported a bankruptcy filing. SEC Form 8-K (Items 1.03,5.02). Source
- Distress
Reported that a debt obligation was accelerated. SEC Form 8-K (Items 2.04). Source
- Listings
Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01,7.01,9.01). Source
- Distress
Reported that a debt obligation was accelerated. SEC Form 8-K (Items 2.04). Source
- Listings
Reported a shareholder vote on a reverse stock split or more authorized shares. SEC Form 8-K (Items 5.02,5.07,9.01). Source
- Listings
Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01). Source
- Listings
Asked shareholders to approve a reverse stock split. SEC Form DEF 14A. Source
Stock chart
Listing details
- Company
- Synergy CHC Corp.
- Ticker
- SNYRQ
- Listing
- OTC
- Country or territory
- United States
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction